RecruitingNCT06581692
Non-invasive Monitoring of Miscarriage
Sponsor
Chinese University of Hong Kong
Enrollment
150 participants
Start Date
Sep 1, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
cfDNA is extremely useful to ascertain chromosomal causes of miscarriages at the point of miscarriage diagnosis by a simple blood test. This study aims to determine the level of cell-free DNA (cfDNA) in early pregnancy and compare the results with those of product of conception (POC) testing, in concordance with standard karyotyping.
Eligibility
Min Age: 18 YearsMax Age: 45 Years
Inclusion Criteria3
- Age 18-45 years.
- Women who attend the early pregnancy loss clinic or Patients who receive ART
- Their partner, the biological father of the pregnancy
Exclusion Criteria2
- History of psychological/ psychiatric problem
- Patient refusal
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERThis is a routine procedure, no intervention will be provided.
This is a routine procedure, no intervention will be provided.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06581692
Related Trials
Comprehensive Assessment of First Trimester Pregnancy Loss
NCT072938192 locations
Letrozole Plus Misoprostol Versus Misoprostol Alone for Treating Women With Missed Miscarriage
NCT071608551 location
Hysteroscopic Resection Versus Manual Vacuum Aspiration for Early Pregnancy
NCT070885101 location
Machine Learning Miscarriage Management Clinical Decision Support Tool Study
NCT063841441 location